Sharda University Researchers Announce Success of Nutraceutical Medication HARAS for Lung Protection for Smokers

Sharda University, in collaboration with Nanoved Research Foundation, has announced successful clinical trials of HARAS, a nanotechnology-based nutraceutical designed to protect smokers’ lungs by significantly reducing carbon monoxide (CO) levels.

Sharda University Researchers Announce Success of Nutraceutical Medication HARAS for Lung Protection for Smokers Read More
Laryngectomy,

Overcoming Laryngectomy: Regaining Voice and Leading a Normal Life

Laryngectomy survivors can lead fulfilling lives. Thanks to modern rehabilitation techniques and a positive outlook. This was the message from experts and survivors at Rajiv Gandhi Cancer Institute and Research Centre’s (RGCIRC) recent patient programme held at Rohini in the national capital.

Overcoming Laryngectomy: Regaining Voice and Leading a Normal Life Read More
Zydus,

Zydus, Daewoong Pharmaceutical collaborate for development and commercialisation of Leuprolide Acetate for Depot Suspension

Zydus Worldwide DMCC, a subsidiary of Zydus Lifesciences Ltd and Daewoong Pharmaceutical on Monday announced that they have entered into an exclusive licensing agreement to co-develop and commercialize Leuprolide Acetate for Depot Suspension (RLD: Lupron Depot®, AbbVie) in six dosage strengths for the United States market.

Zydus, Daewoong Pharmaceutical collaborate for development and commercialisation of Leuprolide Acetate for Depot Suspension Read More